Purespring

Let's transform the treatment of kidney diseases.
We tweet about our cool science, our #Purespringers and making a difference to patients.

[Purespring @Purespringtx]

On #ClinicalTrialsDay, we celebrate the progress made possible through clinical #research. This year, we’re proud to be actively recruiting for our first #ClinicalTrial, a Phase I/II study of PS-002 in #IgAN.

Find out more here: https://t.co/gJWg4g20R4

[Purespring @Purespringtx]

Today is #IgANAwarenessDay, a chronic autoimmune disease that causes kidney failure. New treatment options are critical.

Our Phase I/II trial for PS-002, a podocyte precision therapy, is enrolling in the UK/US to change the treatment landscape. Visit: https://t.co/gJWg4g20R4

[Purespring @Purespringtx]

Today we announced the publication of new #research in Kidney International Reports demonstrating that pathogenic NPHS2 variants are a significant and under-recognised cause of adult-onset FSGS. Read more: https://t.co/GX4G2Eo9tk

#PrecisionNephrology #KidneyDisease

[Purespring @Purespringtx]

Tune in to the latest episode of The BioHub #podcast to hear our CEO, Haseeb Ahmad, discuss how Purespring is aiming to treat the untreatable in #KidneyDisease through our pioneering podocyte-targeted genetically-driven therapies: https://t.co/hQNK7lCMkx

#PrecisionNephrology

[Purespring @Purespringtx]

Get to know our CEO, Haseeb Ahmad, in a new Q&A, where he reflects on his first year as Chief Executive and what he is looking to achieve over the next 12-18 months: https://t.co/QRBle0zosV

#PrecisionNephrology #KidneyDisease #Leadership

[Purespring @Purespringtx]

Our CEO, Haseeb Ahmad, was interviewed by @ByAmyBrown at @BiotechTV to discuss Purespring's growing pipeline of #podocyte-targeted therapies for #KidneyDiseases at @SynconaLtd's Capital Market Day!

Listen here: https://t.co/zG7xZUlSmp

[Purespring @Purespringtx]

Last week, the Purespring team marked #WorldKidneyDay with a bake sale, raising funds for @NSTrust and the Alport Syndrome Alliance.

Thank you to everyone who donated – together we can help patients with #KidneyDiseases live fuller, healthier lives.

[Purespring @Purespringtx]

From 16–18 March, our CMO Fredrik Erlandsson will be in Boston at the 8th Annual CKD Drug Development Summit, joining a panel on how novel modalities can be used to address the unmet needs in chronic #KidneyDisease and also sharing insights from our Phase I/II trial with PS-002.

[Purespring @Purespringtx]

In recognition of #InternationalWomensDay, we asked some of the amazing #WomenInSTEM at Purespring about the impact they hope their work will have and what advice they would give to their younger selves. To meet them, watch the video below.

#IWD26 #Biotech #GeneTherapy

[Purespring @Purespringtx]

Tune in to the Base to Base Biotech #podcast to hear our CEO, Haseeb Ahmad, discuss Purespring's #PrecisionMedicine approach for #kidney disease and his #career journey with host Jim Cornall. Listen here: https://t.co/5hObD8khBY

#Biotech

[Purespring @Purespringtx]

Ahead of #RareDiseaseDay, we would like to shine a spotlight on IgAN, a #rare and chronic kidney condition. There is an urgent need for effective new treatments, but precision approaches targeting the #podocyte could represent a promising step toward more durable outcomes.

[Purespring @Purespringtx]

Last week, in honour of #IDWGS, we gathered together for a lunch and learn panel presentation with some of the amazing #WomenInStem at Purespring, who discussed their career journeys, aspirations and views on the evolving experience of women in science over the years.

#Biotech

[Purespring @Purespringtx]

Purespring’s CEO, Haseeb Ahmad, has been featured in ‘Scrip Asks Part 4: R&D Innovation,’ where he highlights how #GeneTherapy will see a shift from broad-spectrum interventions towards precision, organ-targeted approaches. For more: https://t.co/heRoFdnGNs

#Biotech #Innovation

[Purespring @Purespringtx]

Happy New Year from Purespring. We’re kicking off 2026 by unveiling our new website! The launch reflects our ongoing progress as we prepare to enter the clinic this quarter.

Take a look here: https://t.co/N0m5AaDXVa

#Biotech #Innovation #KidneyDiseases #Podocyte

[Purespring @Purespringtx]

What a year 2025 has been. Thank you to our exceptional and dedicated team for delivering important #milestones for PS-002, including EMA orphan drug designation, FDA IND clearance, and UK CTA approval for our Phase I/II trial.

Happy holidays from the Purespring team! #2026

[Purespring @Purespringtx]

From 12-15 January, the Purespring management team will be in San Francisco, CA for #JPM26. If you are also attending and would like to learn more about our #PrecisionNephrology approach to preserve kidney function, please reach out to arrange a meeting.
#KidneyDisease

[Purespring @Purespringtx]

Getting into the festive spirit, the Purespring team attended @Kidney_Research's first Christmas Carol Concert, uniting the renal community to raise awareness and celebrate progress in kidney #research.

#KidneyDisease #Christmas

[Purespring @Purespringtx]

Our CEO, Haseeb Ahmad, CFO, Sachin Kelkar & VP Business Development and Strategy Nicholas Deakin will be in New York from 2-4 December to #present and participate in 1-to-1 meetings at @Piper_Sandler's 37th Annual Healthcare Conference.

To learn more: https://t.co/bXpgRg5AJa

[Purespring @Purespringtx]

Purespring has been featured as one of @MedCityHQ’s #LifeSciences Companies to Watch 2025, highlighting the strength of our #leadership team, recent progress and potential of our first-in-class genetic therapies to preserve kidney function. Read more here: https://t.co/MNyER6Liwz

[Purespring @Purespringtx]

The Purespring team have left Houston, feeling energised after an engaging #ASN2025! Thank you to ASN #KidneyWeek2025 organisers for an exceptional program, and we are already looking forward to next year!

#GeneticMedicines #KidneyDiseases #Biotech